• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在马拉维的两个地区对艾滋病毒感染者进行早期扩大异烟肼预防性治疗(2017 年)。

Early-phase scale-up of isoniazid preventive therapy for people living with HIV in two districts in Malawi (2017).

机构信息

Global Tuberculosis Prevention and Control Branch, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Center for Global Health, U.S. Centers for Disease Control and Prevention, Lilongwe, Malawi.

出版信息

PLoS One. 2021 Apr 1;16(4):e0248115. doi: 10.1371/journal.pone.0248115. eCollection 2021.

DOI:10.1371/journal.pone.0248115
PMID:33793577
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8016323/
Abstract

BACKGROUND

Isoniazid preventive therapy (IPT) against tuberculosis (TB) is a life-saving intervention for people living with HIV (PLHIV). In September 2017, Malawi began programmatic scale-up of IPT to eligible PLHIV in five districts with high HIV and TB burden. We measured the frequency and timeliness of early-phase IPT implementation to inform quality-improvement processes.

METHODS AND FINDINGS

We applied a two-stage cluster design with systematic, probability-proportional-to-size sampling of six U.S. Centers for Disease Control and Prevention (CDC)-affiliated antiretroviral therapy (ART) centers operating in the urban areas of Lilongwe and Blantyre, Malawi (November 2017). ART clinic patient volume determined cluster size. Within each cluster, we sequentially sampled approximately 50 PLHIV newly enrolled in ART care. We described a quality-of-care cascade for intensive TB case finding (ICF) and IPT in PLHIV. PLHIV newly enrolled in ART care were eligibility-screened for hepatitis and peripheral neuropathy, as well as for TB disease using a standardized four-symptom screening tool. Among eligible PLHIV, the overall weighted IPT initiation rate was 70% (95% CI: 46%-86%). Weighted IPT initiation among persons aged <15 years (30% [95% CI: 12%-55%]) was significantly lower than among persons aged ≥15 years (72% [95% CI: 47%-89%]; Rao-Scott chi-square P = 0.03). HIV-positive children aged <5 years had a weighted initiation rate of only 13% (95% CI: 1%-79%). For pregnant women, the weighted initiation rate was 67% (95% CI: 32%-90%), similar to non-pregnant women aged ≥15 years (72% [95% CI: 49%-87%]). Lastly, 95% (95% CI: 92%-97%) of eligible PLHIV started ART within one week of HIV diagnosis, and 92% (95% CI: 73%-98%) of patients receiving IPT began on the same day as ART.

CONCLUSIONS

Early-phase IPT uptake among adults at ART centers in Malawi was high. Child uptake needed improvement. National programs could adapt this framework to evaluate their ICF-IPT care cascades.

摘要

背景

异烟肼预防治疗(IPT)是挽救生命的干预措施,适用于艾滋病毒(HIV)感染者(PLHIV)。2017 年 9 月,马拉维开始在五个 HIV 和结核病负担较高的地区扩大 IPT 规划,为符合条件的 PLHIV 提供 IPT。我们测量了早期 IPT 实施的频率和及时性,以告知质量改进过程。

方法和发现

我们应用了两阶段聚类设计,对美国疾病控制与预防中心(CDC)附属的六个抗逆转录病毒治疗(ART)中心在马拉维利隆圭和布兰太尔市区运营的情况进行了系统的、按大小比例概率抽样(2017 年 11 月)。ART 诊所的患者量决定了集群的大小。在每个集群中,我们按顺序抽取大约 50 名新入组 ART 护理的 PLHIV。我们描述了密集型结核病病例发现(ICF)和 PLHIV 中 IPT 的护理质量级联。新入组 ART 护理的 PLHIV 接受了乙型肝炎和周围神经病变的资格筛查,以及使用标准化的四项症状筛查工具进行结核病疾病筛查。在符合条件的 PLHIV 中,IPT 起始率加权值为 70%(95%CI:46%-86%)。年龄<15 岁的人群中,IPT 起始率加权值为 30%(95%CI:12%-55%),明显低于年龄≥15 岁的人群(72%[95%CI:47%-89%];Rao-Scott 卡方 P=0.03)。年龄<5 岁的 HIV 阳性儿童 IPT 起始率仅为 13%(95%CI:1%-79%)。对于孕妇,IPT 起始率为 67%(95%CI:32%-90%),与年龄≥15 岁的非孕妇相似(72%[95%CI:49%-87%])。最后,95%(95%CI:92%-97%)的符合条件的 PLHIV 在 HIV 诊断后一周内开始接受 ART 治疗,92%(95%CI:73%-98%)接受 IPT 的患者在同一天开始接受 ART 治疗。

结论

马拉维 ART 中心成人早期 IPT 接受率较高,但儿童接受率需要提高。国家方案可以采用这一框架来评估其 ICF-IPT 护理级联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a056/8016323/21e8d3843b62/pone.0248115.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a056/8016323/2cb9d4df69a3/pone.0248115.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a056/8016323/82fd10b7c7cf/pone.0248115.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a056/8016323/21e8d3843b62/pone.0248115.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a056/8016323/2cb9d4df69a3/pone.0248115.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a056/8016323/82fd10b7c7cf/pone.0248115.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a056/8016323/21e8d3843b62/pone.0248115.g003.jpg

相似文献

1
Early-phase scale-up of isoniazid preventive therapy for people living with HIV in two districts in Malawi (2017).在马拉维的两个地区对艾滋病毒感染者进行早期扩大异烟肼预防性治疗(2017 年)。
PLoS One. 2021 Apr 1;16(4):e0248115. doi: 10.1371/journal.pone.0248115. eCollection 2021.
2
Outcomes of isoniazid preventive therapy among people living with HIV in Kenya: A retrospective study of routine health care data.肯尼亚艾滋病毒感染者中异烟肼预防性治疗的结局:基于常规医疗保健数据的回顾性研究。
PLoS One. 2020 Dec 2;15(12):e0234588. doi: 10.1371/journal.pone.0234588. eCollection 2020.
3
Beneficial effect of isoniazid preventive therapy and antiretroviral therapy on the incidence of tuberculosis in people living with HIV in Ethiopia.异烟肼预防性治疗和抗逆转录病毒疗法对埃塞俄比亚艾滋病毒感染者结核病发病率的有益影响。
PLoS One. 2014 Aug 8;9(8):e104557. doi: 10.1371/journal.pone.0104557. eCollection 2014.
4
Initiation and completion rates of isoniazid preventive therapy among people living with HIV in Far-Western Region of Nepal: a retrospective cohort study.尼泊尔远西部地区 HIV 感染者中异烟肼预防性治疗的启动和完成率:一项回顾性队列研究。
BMJ Open. 2019 May 29;9(5):e029058. doi: 10.1136/bmjopen-2019-029058.
5
Isoniazid preventive therapy: Uptake, incidence of tuberculosis and survival among people living with HIV in Bulawayo, Zimbabwe.异烟肼预防治疗:津巴布韦布拉瓦约艾滋病毒感染者的结核发病率、结核发病情况和生存率。
PLoS One. 2019 Oct 3;14(10):e0223076. doi: 10.1371/journal.pone.0223076. eCollection 2019.
6
Programmatic Evaluation of an Algorithm for Intensified Tuberculosis Case Finding and Isoniazid Preventive Therapy for People Living With HIV in Thailand and Vietnam.泰国和越南针对艾滋病毒感染者开展强化结核病病例发现及异烟肼预防性治疗算法的项目评估。
J Acquir Immune Defic Syndr. 2017 Dec 15;76(5):512-521. doi: 10.1097/QAI.0000000000001551.
7
A prospective cohort study of outcomes for isoniazid prevention therapy: a nested study from a national QI collaborative in Uganda.异烟肼预防性治疗结局的前瞻性队列研究:乌干达一项全国性质量改进协作项目中的嵌套研究
AIDS Res Ther. 2020 May 27;17(1):28. doi: 10.1186/s12981-020-00285-0.
8
Determinants of isoniazid preventive therapy completion among people living with HIV attending care and treatment clinics from 2013 to 2017 in Dar es Salaam Region, Tanzania. A cross-sectional analytical study.坦桑尼亚达累斯萨拉姆地区 2013 年至 2017 年间,接受护理和治疗诊所服务的艾滋病毒感染者中异烟肼预防性治疗完成情况的决定因素。一项横断面分析研究。
BMC Infect Dis. 2020 Apr 10;20(1):276. doi: 10.1186/s12879-020-04997-6.
9
Impact of Isoniazid Preventive Therapy on Tuberculosis incidence among people living with HIV: A secondary data analysis using Inverse Probability Weighting of individuals attending HIV care and treatment clinics in Tanzania.异烟肼预防治疗对 HIV 感染者结核病发病率的影响:利用坦桑尼亚艾滋病毒护理和治疗诊所就诊个体的逆概率加权进行的二次数据分析。
PLoS One. 2021 Jul 13;16(7):e0254082. doi: 10.1371/journal.pone.0254082. eCollection 2021.
10
Assessment of Isoniazid Preventive Therapy and Incidence of Tuberculosis among People Living with Human Immunodeficiency Virus Seeking Care in an Anti-retroviral Therapy Center, Puducherry.评估在一个抗逆转录病毒治疗中心接受治疗的艾滋病毒感染者中异烟肼预防治疗与结核病发病情况。
Indian J Public Health. 2024 Jan 1;68(1):15-20. doi: 10.4103/ijph.ijph_206_23. Epub 2024 Apr 4.

引用本文的文献

1
Characteristics of TPT initiation and completion among people living with HIV.艾滋病毒感染者中开始和完成TPT的特征。
IJTLD Open. 2024 Jan;1(1):11-19. doi: 10.5588/ijtldopen.23.0194.
2
Drop-offs in the isoniazid preventive therapy cascade among children living with HIV in western Kenya, 2015-2019.2015-2019 年肯尼亚西部儿童艾滋病毒感染者中异烟肼预防性治疗级联中的脱落现象。
J Int AIDS Soc. 2022 Aug;25(8):e25939. doi: 10.1002/jia2.25939.
3
Isoniazid-associated pellagra during mass scale-up of tuberculosis preventive therapy: a case-control study.

本文引用的文献

1
Impact of "test and treat" recommendations on eligibility for antiretroviral treatment: Cross sectional population survey data from three high HIV prevalence countries.“检测即治疗”建议对接受抗逆转录病毒治疗资格的影响:来自三个高艾滋病毒流行国家的横断面人口调查数据。
PLoS One. 2018 Nov 26;13(11):e0207656. doi: 10.1371/journal.pone.0207656. eCollection 2018.
2
Pediatric HIV Treatment Gaps in 7 East and Southern African Countries: Examination of Modeled, Survey, and Routine Program Data.7 个东非和南非国家的儿科艾滋病毒治疗差距:模型、调查和常规规划数据的检查。
J Acquir Immune Defic Syndr. 2018 Aug 15;78 Suppl 2:S134-S141. doi: 10.1097/QAI.0000000000001739.
3
异烟肼相关性糙皮病在大规模结核预防性治疗中的发病情况:一项病例对照研究。
Lancet Glob Health. 2022 May;10(5):e705-e714. doi: 10.1016/S2214-109X(22)00096-1.
TB preventive therapy for people living with HIV: key considerations for scale-up in resource-limited settings.
在资源有限的环境下扩大 HIV 感染者的结核预防性治疗:主要考虑因素。
Int J Tuberc Lung Dis. 2018 Jun 1;22(6):596-605. doi: 10.5588/ijtld.17.0758.
4
Assessment of the Isoniazid Preventive Therapy Uptake and Associated Characteristics: A Cross-Sectional Study.异烟肼预防性治疗的接受情况及相关特征评估:一项横断面研究。
Tuberc Res Treat. 2018 May 6;2018:8690714. doi: 10.1155/2018/8690714. eCollection 2018.
5
Predictors of isoniazid preventive therapy completion among adults newly diagnosed with HIV in rural Malawi.预测马拉维农村新诊断为 HIV 的成年人完成异烟肼预防治疗的因素。
Int J Tuberc Lung Dis. 2018 Apr 1;22(4):371-377. doi: 10.5588/ijtld.16.0836.
6
Completion of isoniazid preventive therapy among human immunodeficiency virus positive adults in urban Malawi.马拉维城市中艾滋病毒阳性成年人完成异烟肼预防治疗的情况。
Int J Tuberc Lung Dis. 2018 Mar 1;22(3):273-279. doi: 10.5588/ijtld.17.0370.
7
Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial.异烟肼预防治疗对高 CD4 细胞计数的西非 HIV 感染成年人死亡风险的影响: Temprano ANRS 12136 试验的长期随访。
Lancet Glob Health. 2017 Nov;5(11):e1080-e1089. doi: 10.1016/S2214-109X(17)30372-8.
8
Correlates of isoniazid preventive therapy failure in child household contacts with infectious tuberculosis in high burden settings in Nairobi, Kenya - a cohort study.肯尼亚内罗毕高负担环境下儿童家庭中感染性结核病接触者的异烟肼预防性治疗失败的相关因素——一项队列研究
BMC Infect Dis. 2017 Sep 16;17(1):623. doi: 10.1186/s12879-017-2719-8.
9
High completion rates of isoniazid preventive therapy among persons living with HIV in Swaziland.斯威士兰艾滋病毒感染者中异烟肼预防性治疗的高完成率。
Int J Tuberc Lung Dis. 2017 Oct 1;21(10):1127-1132. doi: 10.5588/ijtld.16.0946.
10
Adherence, tolerability, and outcome after 36 months of isoniazid-preventive therapy in 2 rural clinics of Swaziland: A prospective observational feasibility study.斯威士兰两个农村诊所异烟肼预防性治疗36个月后的依从性、耐受性和结果:一项前瞻性观察性可行性研究。
Medicine (Baltimore). 2017 Sep;96(35):e7740. doi: 10.1097/MD.0000000000007740.